106
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Response to Savolitinib in a Patient with Advanced Poorly Differentiated Lung Carcinoma Positive for a Novel EML4-MET Gene Fusion

ORCID Icon, , , &
Pages 79-84 | Received 30 Sep 2023, Accepted 17 Jan 2024, Published online: 29 Jan 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.